These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31641390)

  • 1. Multicomponent nutritional supplement Oncoxin and its influence on quality of life and therapy toxicity in patients receiving adjuvant chemotherapy.
    Kaidarova DR; Kopp MV; Pokrovsky VS; Dzhugashvili M; Akimzhanova ZM; Abdrakhmanov RZ; Babich EN; Bilan EV; Byakhov AV; Gurov SN; Koroleva IA; Mochalova AS; Povaga SS; Raigorodsky MV; Saifullin AS; Sanz E; Petrovskiy FI
    Oncol Lett; 2019 Nov; 18(5):5644-5652. PubMed ID: 31641390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncoxin nutritional supplement in the management of chemotherapy- and/or radiotherapy-associated oral mucositis.
    Shumsky A; Bilan E; Sanz E; Petrovskiy F
    Mol Clin Oncol; 2019 Apr; 10(4):463-468. PubMed ID: 30931119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of an oral nutritional supplementation on nutritional status and quality of life in patients with colorectal cancer and postoperative adjuvant chemotherapy: A multi-center prospective randomized control trial].
    Yang X; Zhu MW; Xiu DR; Yang Y; Yang GX; Hu WG; Wang ZG; Cui HY; Wei JM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):566-571. PubMed ID: 32521976
    [No Abstract]   [Full Text] [Related]  

  • 4. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncoxin-Viusid
    Fundora Ramos MI; Maden LB; Casanova FO; Cruz FH; Reyes CS; Gato AH; Lyncon IB; González EV; Morales KP; Lence JJ; Sanz E
    Mol Clin Oncol; 2021 Jan; 14(1):5. PubMed ID: 33235733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
    Hurria A; Hurria A; Zuckerman E; Panageas KS; Fornier M; D'Andrea G; Dang C; Moasser M; Robson M; Seidman A; Currie V; VanPoznak C; Theodoulou M; Lachs MS; Hudis C
    J Am Geriatr Soc; 2006 Jul; 54(7):1119-24. PubMed ID: 16866685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
    Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H
    JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
    Peppercorn J; Herndon J; Kornblith AB; Peters W; Ahles T; Vredenburgh J; Schwartz G; Shpall E; Hurd DD; Holland J; Winer E
    Cancer; 2005 Oct; 104(8):1580-9. PubMed ID: 16118805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
    Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.
    Krzyzanowska MK; Julian JA; Powis M; Howell D; Earle CC; Enright KA; Mittmann N; Trudeau ME; Grunfeld E
    BMC Cancer; 2019 Sep; 19(1):884. PubMed ID: 31488084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased survival of patients with end-stage hepatocellular carcinoma due to intake of ONCOXIN®, a dietary supplement.
    Al-Mahtab M; Akbar SM; Khan MS; Rahman S
    Indian J Cancer; 2015; 52(3):443-6. PubMed ID: 26905163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    El-Jawahri A; LeBlanc T; VanDusen H; Traeger L; Greer JA; Pirl WF; Jackson VA; Telles J; Rhodes A; Spitzer TR; McAfee S; Chen YA; Lee SS; Temel JS
    JAMA; 2016 Nov; 316(20):2094-2103. PubMed ID: 27893130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life-related outcomes from a patient-tailored integrative medicine program: experience of Russian-speaking patients with cancer in Israel.
    Sharabi IS; Levin A; Schiff E; Samuels N; Agour O; Tapiro Y; Lev E; Keinan-Boker L; Ben-Arye E
    Support Care Cancer; 2016 Oct; 24(10):4345-55. PubMed ID: 27169571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aidi Injection, a Traditional Chinese Medicine Injection, Could Be Used as an Adjuvant Drug to Improve Quality of Life of Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Analysis.
    Xie G; Cui Z; Peng K; Zhou X; Xia Q; Xu D
    Integr Cancer Ther; 2019; 18():1534735418810799. PubMed ID: 30482065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
    D'Almeida Preto D; Baston MT; Geraige CC; Augusto SB; de Oliveira MA; Mamere AE; Pinto GDJ; Dias JM; De Marchi PRM; Paiva BSR; Paiva CE
    BMC Cancer; 2019 Apr; 19(1):382. PubMed ID: 31023257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
    Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
    Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.